Pharmaceutical preparations for the treatment of stroke; pharmaceuticals for the treatment of neurological disease, pharmaceuticals for the treatment of ischemia, pharmaceuticals for the treatment of neuronal injury, and pharmaceuticals for the treatment of neurodegenerative diseases; pharmaceuticals and pharmaceutical preparations for the treatment of subarachnoid hemorrhage, strokes associated with vascular interventions, traumatic brain injury, surgical brain injuries, radiation-induced br...